Ci bi mu melGis bi ci topp
IA ci Robotik Depo
Liggéeyukaay yi
GUIDE usine
IA ci Chirurgie ak Robotik Chirurgikaal
Surgical robotics includes surgeon-controlled robotic-assisted systems and research on more autonomous tasks.
Déglul tegtal biiIA-nettali · ~2 min
Ci xët wii2 simili jàng
Résumé
AI methods may process images or assist planning, but clinical capability depends on the specific device and study.
Plongeur bu xóot
The da Vinci system is described by its manufacturer as surgeon-controlled robotic assistance. The STAR paper demonstrated supervised autonomous suturing of soft bowel tissue in animal models and describes stereo imaging, tissue-landmark detection and suture planning. The AVOID randomized phase 3 trial used ICG near-infrared fluorescence to assess bowel perfusion and adjust transection lines; its overall 90-day leakage rate was not significantly lower than conventional assessment. These examples do not establish universal autonomy or clinical benefit. In deformable-tissue surgery, tissue movement and visual constraints such as occlusion challenge image-based planning. The AVOID trial’s primary endpoint was clinically relevant anastomotic leakage within 90 days and showed no significant overall reduction with ICG fluorescence. The STAR animal study reports comparative consistency on specific measures including suture spacing and bite depth; it does not establish universal clinical superiority.
Doxal ci àdduna dëgg
Intuitive describes da Vinci as a surgeon-controlled robotic-assisted system operated from a console.
The STAR research robot demonstrated supervised suturing of soft bowel tissue in animal models.
The STAR paper describes stereo imaging and tissue-landmark detection in its planning pipeline.
A randomized AVOID trial studied ICG near-infrared fluorescence for assessing bowel perfusion during colorectal surgery.
Ëlëgu IA ci Chirurgie ak Robotik Chirurgikaal
Research may test additional sensing and planning methods, but claims about clinical benefit, autonomy or regulatory expectations need evidence from a named device, study and jurisdiction. Preserving clinician oversight is presented here as a design recommendation.
Teg ko ci jëf
Lu tax mu am solo
- Kontekst bi ak sàrt yi. Xeetu liggéey bi mooy wane ndax xalaati IA yi dina ñu mëna wéy di jëflante ak dëggantaan.
- Xool kalite. Teg domen yi deñuy indi jafe-jafe ci ni njuumte yi di doxee ak ci xeetu saytu yi.
- Tabax tànneef. Dugalug liggéey bu baax dafay méngale kàttan xarala yi ak def liggéey bi ci kanam.
Moytul
- Wareef yiñ tëral mën nañu dindi prototype yu am doole yi.
- Done yu am taarix mën nañu tënk luy lore ci yenn askan.
- Sistem yu yàgg yi mën nañu indi ay jafe-jafe ci lëkkaloo ak njëg yu nëbbu.
Jéego yi ci topp
- Boole ay kàngam ci domen bi, dalee ko ci kaadar jafe-jafe yi ba ci jàngat bi.
- Nafar ay yoon ngir saytu ak ay këyit balaa ngay tàmbali.
- Teela xool ni ñuy sàmmoonte ak seeni wareef ci wàllu kaaraange.
- Defar ko ci ay fase yu leer ci taxawal ak dellu ginaaw.
Weyal di banneexu
Bulletin bu amul fayda
Jàngal xibaar AI bu bes
Ñatti jaar-jaari IA yuñ firndeel bis bu nekk ci ayu-bis bi, ñu bind leen ci Àngle bu leer. Gratis ba fàww, amul yëgle.
Benn email bis bu nekk ci ayu-bis bi. Benn klik nga dindi abonemaa bi. Dunu musa jaay wala séddoo sa adres.
Nattal sa bopp
Take the AI in Surgery and Surgical Robotics quiz
Feedback ci saasi ci bépp tontu, ak sertifikaa buñ mëna séddoo ak ID buñ mëna saytu soo jàllee ci njàng mi.
Jàppale njàngum IA te doo fay. AI Understanding mbootaay la buy def te Yàlla tax — amul yëgle, amul paywall, musul am. Defal ab sarax
Laaj yi ñuy faral di laaj
What is AI in Surgery and Surgical Robotics?
Surgical robotics includes surgeon-controlled robotic-assisted systems and research on more autonomous tasks. AI methods may process images or assist planning, but clinical capability depends on the specific device and study.
How does the manufacturer describe a da Vinci surgical system?
Intuitive describes da Vinci as a surgeon-controlled robotic-assisted system. This is a manufacturer-described capability, not a prevalence claim.
Lan la robot STAR wane ci njàngum baayima yi?
Smart Tissue Autonomous Robot (STAR) defa tombi boppam tisu bu mbàq yi ci mbaam xuux yi, defar ay tombi ñaw yu gina yamale ay surgeon yu xarañ ci nit ñi ci ap firnde bu magg ci moomel sa bopp bu ñuy saytu.
Lan moo waral barabu operaasioŋ bi gëna tar ci wàllu gis-gis ci ordinatër?
Tisu chirurgikaal bi wuute na ak piyeesu usine yu dëgër yi, tisu chirurgikaal dafay soppeeku saa yu nekk, dafay tooy, di seetlu, te dafay faral di nëbb deret ji, saxaaru cautery, ak jumtukaay, tax segmentation ak topp bu wóor di jafe.
What did the AVOID randomized trial find about ICG fluorescence and the overall 90-day colorectal anastomotic-leak rate?
The AVOID phase 3 trial reported no significant difference in overall 90-day clinically relevant leakage between fluorescence-guided and conventional groups. This is a study result, not a conclusion about every procedure or subgroup.
In the AVOID trial, what did ICG near-infrared fluorescence help surgeons assess?
The randomized AVOID trial used ICG fluorescence to assess bowel perfusion and adjust or keep transection lines. It did not significantly reduce the overall 90-day leak rate in the studied population.
Weyal di jàng
Gid yu jëm ci loolu
Tann nañu yeneen njiit ngir topic bii